Kobayashi Pharmaceutical Co Stock Current Valuation
| KBYPFDelisted Stock | USD 32.49 0.00 0.00% |
Valuation analysis of Kobayashi Pharmaceutical helps investors to measure Kobayashi Pharmaceutical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Kobayashi Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Kobayashi Pharmaceutical is based on 3 months time horizon. Increasing Kobayashi Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kobayashi pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Kobayashi Pharmaceutical Co. Since Kobayashi Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kobayashi Pink Sheet. However, Kobayashi Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 32.49 | Real 27.62 | Hype 32.49 | Naive 32.49 |
The real value of Kobayashi Pink Sheet, also known as its intrinsic value, is the underlying worth of Kobayashi Pharmaceutical Company, which is reflected in its stock price. It is based on Kobayashi Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kobayashi Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Kobayashi Pharmaceutical Co helps investors to forecast how Kobayashi pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kobayashi Pharmaceutical more accurately as focusing exclusively on Kobayashi Pharmaceutical's fundamentals will not take into account other important factors: Kobayashi Pharmaceutical Co Company Current Valuation Analysis
Kobayashi Pharmaceutical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Kobayashi Pharmaceutical Current Valuation | 3.94 B |
Most of Kobayashi Pharmaceutical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kobayashi Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Kobayashi Pharmaceutical Co has a Current Valuation of 3.94 B. This is 79.67% lower than that of the Consumer Defensive sector and 88.91% lower than that of the Household & Personal Products industry. The current valuation for all United States stocks is 76.27% higher than that of the company.
Kobayashi Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kobayashi Pharmaceutical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Kobayashi Pharmaceutical could also be used in its relative valuation, which is a method of valuing Kobayashi Pharmaceutical by comparing valuation metrics of similar companies.Kobayashi Pharmaceutical is currently under evaluation in current valuation category among its peers.
Kobayashi Fundamentals
| Return On Equity | 0.0968 | |||
| Return On Asset | 0.0633 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.94 B | |||
| Shares Outstanding | 76.01 M | |||
| Shares Owned By Insiders | 34.50 % | |||
| Shares Owned By Institutions | 21.77 % | |||
| Price To Earning | 34.29 X | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 155.25 B | |||
| Gross Profit | 88.77 B | |||
| EBITDA | 32.49 B | |||
| Net Income | 19.71 B | |||
| Cash And Equivalents | 116.15 B | |||
| Total Debt | 596 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 3.92 X | |||
| Book Value Per Share | 2,653 X | |||
| Cash Flow From Operations | 22.42 B | |||
| Earnings Per Share | 1.94 X | |||
| Number Of Employees | 3.45 K | |||
| Beta | 0.27 | |||
| Market Capitalization | 5.37 B | |||
| Total Asset | 252.55 B | |||
| Z Score | 5.4 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 252.55 B | |||
| Last Dividend Paid | 84.0 |
About Kobayashi Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kobayashi Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kobayashi Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kobayashi Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Kobayashi Pink Sheet
If you are still planning to invest in Kobayashi Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kobayashi Pharmaceutical's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |